Anti-VEGF as therapy for ROP leads to less myopia, astigmatism

HAMBURG — Anti-VEGF injection might be a valid alternative to laser photocoagulation in retinopathy of prematurity, leading to significantly lower refractive error, according to studies presented at the Euretina meeting.“We started using bevacizumab 3 to 4 years ago, in a lower, 0.4mg dose compared to other studies,” Jost Jonas, MD, said. 

Full Story →